Leharso, Baby Boy D.
HRN: 21-26-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
04/14/2022
04/21/2022
IV
13.5MG
Q24
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes